In the ever-evolving landscape of life sciences, efficient and accurate communication between HCPs and pharmaceutical companies is paramount. Among the many critical processes in this domain, managing medical inquiries stands out as the bridge that connects providers with pharma, offering an essential exchange of information about therapies, programs, and clinical trials.
Addressing these inquiries are medical information and communication teams, ensuring HCPs receive precise, comprehensive, and detailed answers for optimal patient care. However, these teams also grapple with a multitude of challenges, from the need for rapid responses to complex medical literature databases. As a result, drafting medical response documents (MRDs) can be a time-consuming task as well as an inefficient use of their clinical expertise.
ZoomRx’s Ferma Engine is a generative AI (GenAI) platform that streamlines the challenging and time-intensive processes associated with medical inquiries. It empowers medical information and communication teams by automating the tedious tasks of searching for relevant citations on PubMed and OVID and extracting their key insights.
Utilizing its comprehensive training, the Ferma Engine then uses GenAI to produce an MRD draft according to the imported clinical findings and specified formatting protocols. The entire process transforms medical information and communications teams from document creators to document reviewers, harnessing their clinical expertise where it matters most.
Early users report time savings anywhere from 50-75% per MRD, depending on the complexity of the medical inquiry. As pharmaceutical companies increasingly adopt the Ferma Engine, the industry is moving toward a future where medical inquiries are handled with unprecedented efficiency and precision, benefiting both HCPs and patients alike.
